openPR Logo
Press release

Aspirin AI Launches Globally: The First AI Pharmacist Aims to reduce Medication Errors

08-19-2025 02:29 PM CET | IT, New Media & Software

Press release from: DrGuide ltd

Aspirin AI launches first AI Pharmacist to reduce medication errors.

Aspirin AI launches first AI Pharmacist to reduce medication errors.

With over 8 billion people and only 4 million pharmacists worldwide, medication safety has reached crisis levels. Studies show that 53% of avoidable harm is linked to medication-related issues, and in the UK alone, 377 million medication errors occur annually.

Aspirin AI, created by UK-based DrGuide.net and led by senior professional pharmacists Salman Chishti and Serge Haykin, has launched as the world's first AI Pharmacist. Built specifically for doctors, nurses, pharmacists, carers, patients, and students, Aspirin AI delivers instant, pharmacist-grade answers across 19 critical medicine data points, including:
Name & Classification
Indications & Dosing
Contraindications & Warnings
Interactions & Patient Counselling
Use in Pregnancy, Children, Elderly, Kidney & Liver disease

"Pharmacists are the only qualified experts in the safe use of medicines, yet we are far too few. No one should suffer because clear medicine information isn't available at the right moment. Aspirin AI is our answer - a tool to empower every professional, patient, and family to make safer medicine decisions instantly." said Salman Chishti, Co-Founder of DrGuide.net.

Since its initial Android release in June 2025 (over 300+ organic downloads without paid promotion), Aspirin AI has now launched on iOS (August 2025) and Web - making it globally accessible.

Aspirin AI is calling on healthcare professionals worldwide - doctors, nurses, pharmacists, carers, and students - to join its mission to reduce the global pandemic of medication errors.

Availability:
iOS: https://apps.apple.com/gb/app/aspirin-ai/id6746511623
Android: https://play.google.com/store/apps/details?id=appdrguidenet.wpapp
Web: https://DrGuide.net

Salman Chishti
London, UK
https://drguide.net/about-us/

CKR House. Dartford. DA1 1RZ. England. UK

DrGuide.net is a UK-based digital health platform dedicated to improving global medicine safety through accessible, accurate, and instant information. Founded by pharmacists Salman Chishti and Serge Haykin, DrGuide.net builds tools for clinicians, patients, and families to reduce harm from medicines and improve outcomes worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aspirin AI Launches Globally: The First AI Pharmacist Aims to reduce Medication Errors here

News-ID: 4148276 • Views:

More Releases for Aspirin

Electronic Aspirin Market Size Analysis by Application, Type, and Region: Foreca …
USA, New Jersey- According to Market Research Intellect, the global Electronic Aspirin market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. PARA Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchintellect.com/download-sample/?rid=1015768&utm_source=OpenPr&utm_medium=867 Market Growth Drivers-Electronic Aspirin Market: The growth of the Electronic
Aspirin Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 | …
The global aspirin market is anticipated to grow at a considerable CAGR of 3.6 % during the forecast period (2023-2030). Aspirin can be used to treat a wide range of diseases, including cancer, diabetes, cryptococcal infection, and abnormalities of the nervous system, owing to it has an impact on both Cyclooxygenase (COX)-dependent and Cyclooxygenase COX-independent pathways. Aspirin as one of the ingredients for creating specialized healthcare products such as hydrogels.
Aspirin Enteric-Coated Tablets Market will Witness Huge Growth till 2028 & Covid …
Implementing an innovative market strategy allows market players to leverage the sales growth and it also tells whether your novel product launch will bring larger revenues or not. It is crucial to obtain all the details regarding market competition to survive in the competitive market. Clear picture on the competitive market is also covered in this Aspirin Enteric-Coated Tablets market report along with covering legal, economic and demographic problems. It
Global Aspirin Market 2015-2025 | Growing Opportunities and Trends in Aspirin Ma …
The Market Research Store has added the latest report on the Global Aspirin Market which includes the historical data from 2015 to 2019 and has also precisely forecasted data from 2020 to 2025. The global Aspirin market anticipates to showcase market value in terms of USD Million during the forecast period 2020 to 2025. According the research analyst the market will witness a steady growth during the coming years. Get Sample
Electronic Aspirin Market :How the Electronic Aspirin Market will perform in Upc …
Frequent headaches in the changing lifestyle are a very common condition. Stress related to work has increased significantly in recent times. People have therefore resorted to self-medicate with a known analgesic brand. Aspirin is the most popular brand available for headache globally. Developed for headache and pain, Aspirin have extended indications now for heart attack and stroke. Moreover, it is estimated that nearly 700 to 1000 clinical trials are conducted
Electronic Aspirin Market :How the Electronic Aspirin Market will perform in Upc …
Frequent headaches in the changing lifestyle are a very common condition. Stress related to work has increased significantly in recent times. People have therefore resorted to self-medicate with a known analgesic brand. Aspirin is the most popular brand available for headache globally. Developed for headache and pain, Aspirin have extended indications now for heart attack and stroke. Moreover, it is estimated that nearly 700 to 1000 clinical trials are conducted